Bluetooth earphones have become daily essentials, and these picks balance sound quality, comfort, battery life and reliable ...
Beam Global (NASDAQ:BEEM) Q3 2025 Earnings Call Transcript November 14, 2025 Beam Global misses on earnings expectations. Reported EPS is $-0.28 EPS, expectations were $-0.25. Operator: Good afternoon ...
This incredible parallel bars dismount is not yet featured in the Men’s Code of Points: it consists of a triple back in a ...
Photronics, Inc.'s Q4 earnings showed solid growth in its high-end IC segment, which posted record revenues and mix. Read why ...
This article is part of Gizmodo Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Reading time 3 minutes Most TVs focus on the ...
The name "Ozempic 2.0" has been floating around on various outlets and on social media, as a trending nickname for the next generation of weight loss drugs that are in the works for 2026. Both Eli ...
The Oklahoma Ethics Commission is set to consider restoring a previous version of its Guardian System at a meeting Friday, ...
Jim Beam, the country’s largest maker of bourbon, has announced a one-year pause in production at its flagship facility in ...
Beam today announced the launch of its Veo 3.1-powered playable video platform, a new AI creation tool that allows creators to turn ordinary videos into playable mini-games and interactive AI stories ...
Eight months ago, InvestingPro’s Fair Value model identified something that many investors missed: Beam Therapeutics (NASDAQ:BEAM), a gene editing biotechnology company, was significantly undervalued.
BEAM announced an update to internal documentation outlining how AI-supported quantity takeoffs are being integrated with bid estimating software to support changes in bid volume management and ...
Bourbon maker Jim Beam is halting production at one of its distilleries in Kentucky for at least a year as the whiskey industry navigates tariffs from the Trump administration and slumping demand for ...